These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1539079

  • 1. Naloxone as a stimulus in drug discrimination learning: generalization to other opiate antagonists.
    Smurthwaite ST, Kautz MA, Geter B, Riley AL.
    Pharmacol Biochem Behav; 1992 Jan; 41(1):43-7. PubMed ID: 1539079
    [Abstract] [Full Text] [Related]

  • 2. Diprenorphine as a stimulus in drug discrimination learning.
    Smurthwaite ST, Riley AL.
    Pharmacol Biochem Behav; 1992 Nov; 43(3):839-46. PubMed ID: 1333085
    [Abstract] [Full Text] [Related]

  • 3. Nalorphine as a stimulus in drug discrimination learning: assessment of the role of mu- and kappa-receptor subtypes.
    Smurthwaite ST, Riley AL.
    Pharmacol Biochem Behav; 1994 Jul; 48(3):635-42. PubMed ID: 7938116
    [Abstract] [Full Text] [Related]

  • 4. Buprenorphine as a stimulus in drug discrimination learning: an assessment of mu and kappa receptor activity.
    Pournaghash S, Riley AL.
    Pharmacol Biochem Behav; 1993 Nov; 46(3):593-604. PubMed ID: 8278436
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning.
    Davis CM, Stevenson GW, Cañadas F, Ullrich T, Rice KC, Riley AL.
    Psychopharmacology (Berl); 2009 Apr; 203(2):421-9. PubMed ID: 18594795
    [Abstract] [Full Text] [Related]

  • 6. An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure.
    Melton PM, Riley AL.
    Pharmacol Biochem Behav; 1993 Sep; 46(1):237-42. PubMed ID: 8255917
    [Abstract] [Full Text] [Related]

  • 7. Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin.
    Riley AL, Melton PM.
    Pharmacol Biochem Behav; 1997 Sep; 57(1-2):57-62. PubMed ID: 9164554
    [Abstract] [Full Text] [Related]

  • 8. Antagonism of drug discrimination learning within the conditioned taste aversion procedure.
    Stevenson GW, Pournaghash S, Riley AL.
    Pharmacol Biochem Behav; 1992 Jan; 41(1):245-9. PubMed ID: 1539076
    [Abstract] [Full Text] [Related]

  • 9. Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose.
    Grabus SD, Smurthwaite ST, Riley AL.
    Pharmacol Biochem Behav; 1999 Jul; 63(3):481-8. PubMed ID: 10418791
    [Abstract] [Full Text] [Related]

  • 10. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE, Holtzman SG.
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [Abstract] [Full Text] [Related]

  • 11. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP, Woods JH.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [Abstract] [Full Text] [Related]

  • 12. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP, Woods JH.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
    [Abstract] [Full Text] [Related]

  • 13. Cholecystokinin as a stimulus in drug discrimination learning.
    Melton PM, Kopman JA, Riley AL.
    Pharmacol Biochem Behav; 1993 Feb; 44(2):249-52. PubMed ID: 8383337
    [Abstract] [Full Text] [Related]

  • 14. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [Abstract] [Full Text] [Related]

  • 15. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC, Janssen PA.
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [Abstract] [Full Text] [Related]

  • 16. Discriminative stimulus properties of naloxone.
    Carter RB, Leander JD.
    Psychopharmacology (Berl); 1982 Jul; 77(4):305-8. PubMed ID: 6291084
    [Abstract] [Full Text] [Related]

  • 17. Delta opioid discrimination learning in the rat: assessment with the selective delta agonist SNC80.
    Stevenson GW, Cañadas F, Gomez-Serrano M, Ullrich T, Zhang X, Rice KC, Riley AL.
    Pharmacol Biochem Behav; 2002 Jul; 71(1-2):283-92. PubMed ID: 11812534
    [Abstract] [Full Text] [Related]

  • 18. Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism.
    Stevenson GW, Cañadas F, Zhang X, Rice KC, Riley AL.
    Pharmacol Biochem Behav; 2000 Aug; 66(4):851-6. PubMed ID: 10973525
    [Abstract] [Full Text] [Related]

  • 19. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH, Code RA.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [Abstract] [Full Text] [Related]

  • 20. Assessment of SNC 80 and naltrindole within a conditioned taste aversion design.
    Hutchinson AC, Simpson GR, Randall JF, Zhang X, Calderon SN, Rice KC, Riley AL.
    Pharmacol Biochem Behav; 2000 Aug; 66(4):779-87. PubMed ID: 10973516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.